EMILY DAVISON: Open Payments
NPI 1861127565 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,004 in 163 payments from 17 companies in 2025. Trend: 2023 $3,262 · 2024 $2,513 · 2025 $3,004
Food & beverage: $3,004
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 22 | $334 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $329 |
| Otsuka America Pharmaceutical, Inc. | 20 | $303 |
| Neurocrine BioSciences, Inc. | 12 | $297 |
| ABBVIE INC. | 15 | $246 |
| Teva Pharmaceuticals USA, Inc. | 9 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $193 |
| Vanda Pharmaceuticals Inc. | 7 | $183 |
| Collegium Pharmaceutical, Inc. | 10 | $170 |
| Janssen Pharmaceuticals, Inc | 6 | $145 |
Products named: REXULTI, CAPLYTA, INGREZZA, VRAYLAR, AUSTEDO XR, TRINTELLIX, FANAPT, Jornay PM.
Industry payments across NY — which companies pay providers there.
